Home > Healthcare > Medical Devices > Therapeutic Devices > Patient-controlled Analgesic Pumps Market

Patient-controlled Analgesic Pumps Market Trends

Report ID: GMI7971
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Patient-controlled Analgesic Pumps Market Trends

The growing demand for integrating smart technologies into PCA pumps, increasing emphasis on customization and personalized pain management devices, growing utilisation of multimodal analgesia, and rising trend towards using PCA pumps in outpatient settings and for home infusion, among other factors collectively contribute to the evolving landscape of the market.

There is a growing trend towards integrating smart technologies into PCA pumps to improve their efficiency and aid better patient experience. Smart pumps may include features such as connectivity, data monitoring, and integration with electronic health records (EHR). Such developments enhance the monitoring of patient responses and contribute to more personalized pain management.
Moreover, wireless and remote monitoring capabilities are gaining significance in the PCA pumps market. These features enable healthcare personnels to remotely monitor patients' pain levels, pump usage, and possible concerns, resulting in improved patient care and reaction times.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Patient-controlled analgesic pumps industry reached USD 453.9 million in revenue in 2023 and is projected to be worth USD 697.4 million by 2032 driven by the increasing number of surgical procedures and the ongoing advancements in pain management technologies

The electronic and wireless segment generated USD 306.6 million in 2023 and is projected to gain significant traction through 2032 due to the strong need to enable remote monitoring and facilitate integration with telehealth platforms.

North America patient-controlled analgesic pumps industry size was USD 183.3 million in 2023 and is estimated to exhibit robust growth through 2032 driven by the growing prevalence of chronic pain problems and the presence of an advanced healthcare infrastructure in the region.

Some leading companies engaged in the market are B. Braun Medical Inc., Abbott Laboratories, Ace-medical, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE & Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, and SCW MEDICATH LTD.